Search Results - "Tett, Susan E."

Refine Results
  1. 1

    Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update by Staatz, Christine E., Tett, Susan E.

    Published in Archives of toxicology (01-07-2014)
    “…This review aims to provide an update of the literature on the pharmacology and toxicology of mycophenolate in solid organ transplant recipients. Mycophenolate…”
    Get full text
    Journal Article
  2. 2

    Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients by Staatz, Christine E., Tett, Susan E.

    Published in Clinical pharmacokinetics (01-10-2015)
    “…Tacrolimus is a pivotal immunosuppressant agent used in solid-organ transplantation. It was originally formulated for oral administration as Prograf ® , a…”
    Get full text
    Journal Article
  3. 3

    Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients by STAATZ, Christine E, TETT, Susan E

    Published in Clinical pharmacokinetics (2007)
    “…This review aims to provide an extensive overview of the literature on the clinical pharmacokinetics of mycophenolate in solid organ transplantation and a…”
    Get full text
    Journal Article
  4. 4

    Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I by Staatz, Christine E., Goodman, Lucy K., Tett, Susan E.

    Published in Clinical pharmacokinetics (01-03-2010)
    “…The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ rejection following…”
    Get full text
    Journal Article
  5. 5

    Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II by Staatz, Christine E., Goodman, Lucy K., Tett, Susan E.

    Published in Clinical pharmacokinetics (01-04-2010)
    “…The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant drugs used for the prevention of organ rejection following…”
    Get full text
    Journal Article
  6. 6

    Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation by STAATZ, Christine E, TETT, Susan E

    Published in Clinical pharmacokinetics (01-01-2004)
    “…The aim of this review is to analyse critically the recent literature on the clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ…”
    Get full text
    Journal Article
  7. 7

    Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation by Kuypers, Dirk R J, Le Meur, Yannick, Cantarovich, Marcelo, Tredger, Michael J, Tett, Susan E, Cattaneo, Dario, Tönshoff, Burkhard, Holt, David W, Chapman, Jeremy, Gelder, Teun van

    “…With the increasing use of mycophenolic acid (MPA) in solid organ transplantation, the need for more accurate drug dosing has become evident. Personalized…”
    Get full text
    Journal Article
  8. 8

    Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—A meta-analysis by Roos, Juliana F., Doust, Jenny, Tett, Susan E., Kirkpatrick, Carl M.J.

    Published in Clinical biochemistry (01-03-2007)
    “…To perform a systematic review comparing the diagnostic accuracy of CysC with SCr. MEDLINE and EMBASE (January 1984–February 2006) were searched. Studies…”
    Get full text
    Journal Article
  9. 9

    Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients by Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett, Staatz, Christine E.

    Published in Clinical drug investigation (01-12-2019)
    “…Background and Objectives Mycophenolic acid (MPA) is commonly used following renal transplant. Saliva MPA concentrations may reflect the pharmacologically…”
    Get full text
    Journal Article
  10. 10

    Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life? by Gardiner, Kyle M., Tett, Susan E., Staatz, Christine E.

    Published in Drugs in R&D (01-12-2018)
    “…Background Globally, enteric-coated mycophenolate sodium (EC-MPS) is replacing mycophenolate mofetil (MMF) in maintenance immunosuppressant regimens. The…”
    Get full text
    Journal Article
  11. 11

    Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure by Tett, Susan E, Saint-Marcoux, Franck, Staatz, Christine E, Brunet, Merce, Vinks, Alexander A, Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R, van Gelder, Teun, Cattaneo, Dario

    Published in Transplantation reviews (Orlando, Fla.) (01-04-2011)
    “…Abstract This article summarizes part of a consensus meeting about mycophenolate (MPA) therapeutic drug monitoring held in Rome under the auspices of The…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Improving the use of benzodiazepines--is it possible? A non-systematic review of interventions tried in the last 20 years by Smith, Alesha J, Tett, Susan E

    Published in BMC health services research (30-11-2010)
    “…Benzodiazepines are often used on a long term basis in the elderly to treat various psychological disorders including sleep disorders, some neurological…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration by DelDot, Megan E., Lipman, Jeffrey, Tett, Susan E.

    Published in British journal of clinical pharmacology (01-09-2004)
    “…Aims To investigate the pharmacokinetics of vancomycin in critically ill patients on continuous venovenous haemodiafiltration (CVVHDF), a continuous renal…”
    Get full text
    Journal Article
  16. 16

    Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet? by Brooks, Emily, Tett, Susan E., Isbel, Nicole M., Staatz, Christine E.

    Published in Clinical pharmacokinetics (01-11-2016)
    “…This review summarises the available data on the population pharmacokinetics of tacrolimus and use of Maximum A Posteriori (MAP) Bayesian estimation to predict…”
    Get full text
    Journal Article
  17. 17

    Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing by Barozzi, Nadia, PhD, Tett, Susan E., PhD, MPS

    Published in Clinical therapeutics (01-04-2009)
    “…Abstract Background: In Australia, the prescribing of proton pump inhibitors (PPIs) and histamine type 2 receptor antagonists (H2 RAs) for defined…”
    Get full text
    Journal Article
  18. 18

    Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant by Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I., Tett, Susan E.

    Published in British journal of clinical pharmacology (01-03-2005)
    “…Aims The pharmacokinetics of mycophenolic acid and its glucuronide are complex. This study investigated the pharmacokinetics, pharmacodynamics and protein…”
    Get full text
    Journal Article
  19. 19

    Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia by Barozzi, Nadia, Tett, Susan E

    Published in BMC health services research (24-09-2008)
    “…Cross national drug utilization studies can provide information about different influences on physician prescribing. This is important for medicines with…”
    Get full text
    Journal Article
  20. 20

    Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation by STAATZ, Christine E, DUFFULL, Stephen B, KIBERD, Bryce, FRASER, Albert D, TETT, Susan E

    Published in European journal of clinical pharmacology (01-08-2005)
    “…To investigate the population pharmacokinetics of mycophenolic acid (MPA) in adult kidney transplant recipients during the crucial first week after…”
    Get full text
    Journal Article